At Dolan Memory Care Homes, we are committed to offering compassionate, individualized care for residents living with Alzheimer’s and other forms of dementia. As part of our commitment to families, we closely follow new research that may impact the lives of those we serve. A recent study from Washington University School of Medicine offers encouraging news about a treatment that may help slow the progression of early-stage Alzheimer’s disease.
Encouraging Results for Lecanemab in Real-World Use
The study focused on lecanemab, an FDA-approved medication designed to slow the progression of Alzheimer’s by targeting amyloid plaques in the brain. While clinical trials had already shown promise, this study is especially noteworthy because it examined how the drug performs in real-world settings—outside of a controlled trial.
Among 234 patients with very mild to mild Alzheimer’s:
- Only about 1% experienced serious side effects requiring hospitalization.
- Patients in the earliest stage of Alzheimer’s fared best, with just 1.8% experiencing complications.
- Most side effects were mild, temporary, and detected through routine imaging.
- No deaths were reported.
These results reinforce that lecanemab may be a safe and effective option, especially when started in the earliest stages of Alzheimer’s.
Why It Matters to the Dolan Community
At Dolan Memory Care, we believe that informed families are empowered families. This study reinforces what we already practice: the importance of early detection, individualized support, and close communication with medical professionals.
For families seeking memory care in St. Louis County, Dolan offers a unique, person-centered approach rooted in empathy, clinical excellence, and family collaboration. Our philosophy of care emphasizes:
- Small, homelike environments for more personalized attention
- Round-the-clock nursing and access to healthcare partners
- Support for both residents and their families throughout the journey
You can learn more about our approach to Alzheimer’s care here.
How Families Can Take Action
If your loved one is in the early stages of Alzheimer’s, now may be the time to explore options like lecanemab. Here’s what we recommend:
- Talk to your loved one’s neurologist or primary care provider about whether lecanemab might be appropriate.
- Understand the treatment process—lecanemab is administered through twice-monthly infusions and includes regular imaging to monitor for side effects.
- Stay connected to your care team—we’re happy to coordinate with your loved one’s providers and help you navigate the decision-making process.
At Dolan, our homes are designed to provide care at every stage of dementia. For families looking for high-quality, relationship-based memory care in St. Louis County, we offer stability, consistency, and warmth. Whether your loved one is newly diagnosed or needs more advanced support, we are here to provide a nurturing environment that respects their dignity and fosters meaningful connection. Learn more about our residential care homes here.
Looking Ahead
The Alzheimer’s journey can be difficult, but new treatments like lecanemab offer hope for more time, more connection, and more independence—especially in the early stages. At Dolan Memory Care Homes, we are staying informed so we can continue to provide the best possible care for our residents and their families.
If you’re searching for memory care in St. Louis County that offers both innovation and compassion, we invite you to connect with us. We’re always here to listen, guide, and support.
Contact us today to schedule a tour or speak with a member of our care team: https://dolancare.com/contact/
Dolan Memory Care Homes | Trusted Alzheimer’s & Dementia Care in St. Louis County
